Molecular Endocrinology, Vol 7, 1226-1239, Copyright © 1993 by Endocrine Society

ARTICLES

Demonstration of nuclear translocation of the mineralocorticoid receptor (MR) using an anti-MR antibody and confocal laser scanning microscopy

NM Robertson, G Schulman, S Karnik, E Alnemri and G Litwack
Department of Pharmacology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

Using a synthetic peptide that corresponds to a unique region of the N- terminal domain of the human mineralocorticoid receptor (MR), amino acids 87-96, we have generated a polyclonal antibody, human (h) MRsN. This sequence shares no homology with the corresponding sequences of the glucocorticoid receptor or other steroid/thyroid hormone receptor superfamily members. Antibody hMRsN cross-reacts with MR from human, rat, and mouse cells and recognizes denatured MR from either crude preparations or partially purified rat kidney cytosol, rat colon, or recombinant hMR overexpressed in baculovirus-infected Sf9 cells. Immunoprecipitation of the native MR from either partially purified or crude preparations of rat kidney cytosol with hMRsN, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver stain, demonstrated a major protein band with a mol wt of 116 kilodaltons. In addition, using confocal laser scanning microscopy and digital image analysis, the immunocytochemical localization of the recombinant hMR over-expressed in Sf9 cells 24 h post-transfection was determined. In the absence of ligand, the MR was detected solely in the cytoplasm, after a 30-min exposure to 100 nM aldosterone the MR was perinuclear, and after 60 min, the MR was predominantly nuclear. To ascertain that this phenomenon was not unique to insect cells, aldosterone induced MR nuclear translocation in mouse macrophage cells was also demonstrated immunocytochemically, clearly indicating a role for nuclear translocation in MR function.

This article has been cited by other articles:

				M. Nishi and M. Kawata Brain Corticosteroid Receptor Dynamics and Trafficking: Implications from Live Cell Imaging Neuroscientist, April 1, 2006; 12(2): 119 - 133. [Abstract] [PDF]

				C. E. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, J. Estess, M. P. Warden, M. T. Gomez-Sanchez, and E. P. Gomez-Sanchez Development of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor Endocrinology, March 1, 2006; 147(3): 1343 - 1348. [Abstract] [Full Text] [PDF]

				R. F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, L. Visentin, C. Lamprecht, G. C. Addicks, R. J. G. Hache, and Y. A. Lefebvre A Serine/Threonine-rich Motif Is One of Three Nuclear Localization Signals That Determine Unidirectional Transport of the Mineralocorticoid Receptor to the Nucleus J. Biol. Chem., April 29, 2005; 280(17): 17549 - 17561. [Abstract] [Full Text] [PDF]

				B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF]

				S. L. Planey, A. Derfoul, A. Steplewski, N. M. Robertson, and G. Litwack Inhibition of Glucocorticoid-induced Apoptosis in 697 Pre-B Lymphocytes by the Mineralocorticoid Receptor N-terminal Domain J. Biol. Chem., October 25, 2002; 277(44): 42188 - 42196. [Abstract] [Full Text] [PDF]

				G. Piwien-Pilipuk, A. Ayala, A. Machado, and M. D. Galigniana Impairment of Mineralocorticoid Receptor (MR)-dependent Biological Response by Oxidative Stress and Aging. CORRELATION WITH POST-TRANSLATIONAL MODIFICATION OF MR AND DECREASED ADP-RIBOSYLATABLE LEVEL OF ELONGATION FACTOR 2 IN KIDNEY CELLS J. Biol. Chem., March 29, 2002; 277(14): 11896 - 11903. [Abstract] [Full Text] [PDF]

				M.-C. Zennaro, A. Souque, S. Viengchareun, E. Poisson, and M. Lombes A New Human MR Splice Variant Is a Ligand-Independent Transactivator Modulating Corticosteroid Action Mol. Endocrinol., September 1, 2001; 15(9): 1586 - 1598. [Abstract] [Full Text] [PDF]

				M. Nishi, H. Ogawa, T. Ito, K.-I. Matsuda, and M. Kawata Dynamic Changes in Subcellular Localization of Mineralocorticoid Receptor in Living Cells: In Comparison with Glucocorticoid Receptor using Dual-Color Labeling with Green Fluorescent Protein Spectral Variants Mol. Endocrinol., July 1, 2001; 15(7): 1077 - 1092. [Abstract] [Full Text] [PDF]

				Y. Wan, K. K. Coxe, V. G. Thackray, P. R. Housley, and S. K. Nordeen Separable Features of the Ligand-Binding Domain Determine the Differential Subcellular Localization and Ligand-Binding Specificity of Glucocorticoid Receptor and Progesterone Receptor Mol. Endocrinol., January 1, 2001; 15(1): 17 - 31. [Abstract] [Full Text]

				T. Michigami, A. Suga, M. Yamazaki, C. Shimizu, G. Cai, S. Okada, and K. Ozono Identification of Amino Acid Sequence in the Hinge Region of Human Vitamin D Receptor That Transfers a Cytosolic Protein to the Nucleus J. Biol. Chem., November 19, 1999; 274(47): 33531 - 33538. [Abstract] [Full Text] [PDF]

				A. Naray-Fejes-Toth and G. Fejes-Toth Extranuclear Localization of Endogenous 11{beta}-Hydroxysteroid Dehydrogenase-2 in Aldosterone Target Cells Endocrinology, June 1, 1998; 139(6): 2955 - 2959. [Abstract] [Full Text] [PDF]

				S. S. Lim-Tio and P. J. Fuller Intracellular Signaling Pathways Confer Specificity of Transactivation by Mineralocorticoid and Glucocorticoid Receptors Endocrinology, April 1, 1998; 139(4): 1653 - 1661. [Abstract] [Full Text] [PDF]

				G. Fejes-Toth, D. Pearce, and A. Naray-Fejes-Toth Subcellular localization of mineralocorticoid receptors in living cells: Effects of receptor agonists and antagonists PNAS, March 17, 1998; 95(6): 2973 - 2978. [Abstract] [Full Text] [PDF]

				M. Shimojo, M. L. Ricketts, M. D. Petrelli, P. Moradi, G. D. Johnson, A. R. Bradwell, M. Hewison, A. J. Howie, and P. M. Stewart Immunodetection of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Mineralocorticoid Target Tissues: Evidence for Nuclear Localization Endocrinology, March 1, 1997; 138(3): 1305 - 1311. [Abstract] [Full Text] [PDF]

				P. C. White, T. Mune, and A. K. Agarwal 11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess Endocr. Rev., February 1, 1997; 18(1): 135 - 156. [Abstract] [Full Text]

				C. Massaad, M. Lombes, M. Aggerbeck, M.-E. Rafestin-Oblin, and R. Barouki Cell-Specific, Promoter-Dependent Mineralocorticoid Agonist Activity of Spironolactone Mol. Pharmacol., February 1, 1997; 51(2): 285 - 292. [Abstract] [Full Text] [PDF]

				A. Naray-Fejes-Toth and G. Fejes-Toth Subcellular Localization of the Type 211beta -Hydroxysteroid Dehydrogenase. A GREEN FLUORESCENT PROTEIN STUDY J. Biol. Chem., June 28, 1996; 271(26): 15436 - 15442. [Abstract] [Full Text] [PDF]

				M.-O. Lee, M. I. Dawson, N. Picard, P. D. Hobbs, and M. Pfahl A Novel Class of Retinoid Antagonists and Their Mechanism of Action J. Biol. Chem., May 17, 1996; 271(20): 11897 - 11903. [Abstract] [Full Text] [PDF]

				A. Odermatt, P. Arnold, and F. J. Frey The Intracellular Localization of the Mineralocorticoid Receptor Is Regulated by 11beta -Hydroxysteroid Dehydrogenase Type 2 J. Biol. Chem., July 20, 2001; 276(30): 28484 - 28492. [Abstract] [Full Text] [PDF]